Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction.

Slides:



Advertisements
Similar presentations
Module 4 Rotavirus vaccine administration
Advertisements

Training for rotavirus vaccine introduction
Module 1 Introduction to rotavirus disease and vaccine
Module 3 Rotavirus vaccine eligibility
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
Module 6 Rotavirus vaccine AEFI monitoring
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 4 Rotavirus vaccine administration.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Poliomyelitis First described by Michael Underwood in 1789 First outbreak described in U.S. in ,000 paralytic cases reported in the U. S. in 1952.
Training for rotavirus vaccine introduction Module 5 Recording and monitoring uptake of rotavirus vaccine.
Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
Immunisation Update. Changes to the immunisation schedule Contraindications and precautions to vaccination Epidemic update.
Polio and Polio Vaccine
Training for rotavirus vaccine introduction Module 7 Communicating about rotavirus vaccine with caretakers.
EPI VACCINES. BCG ( Bacille Calmette- Guerin)  Protects infants against TB  In powder form with diluents  Must be discarded after 6 hrs. or at the.
Polio Eradication and End Game Strategy
IMMUNITY IMMYNIZATION IMMUNITY. Active immunity are defenses developed by the body that last many years or even a life time. Active immunity are defenses.
Epidemiology of Poliomyelitis Ashry Gad Mohamed MBchB, MPH, DrPH Prof. of Epidemiology Medical College, KSU.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 1 Introduction to rotavirus disease and vaccine.
Module 4 IPV vaccine administration Training for Inactivated Poliovirus Vaccine (IPV) introduction.
World Health Organization
Module 7 Communicating with parents, caregivers and health personnel about IPV and multiple injections Training for Inactivated Poliovirus Vaccine (IPV)
Module 6 Monitoring Events Supposedly Attributable to Vaccination or Immunization (ESAVIs) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Module 5 Recording and monitoring administration of the Inactivated Polio Vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
Module 5 Recording and monitoring uptake of rotavirus vaccine
Introduction to the polio endgame rationale and IPV vaccine
Fractional IPV (fIPV) eligibility
The next phase of polio eradication and the vaccines used
Module 7 Communicating about CD-JEV vaccine with caregivers
Module 8 Safety and acceptability of multiple injections
Safety and acceptability of multiple injections
Communicating with caregivers about IPV and multiple injections
CD-JEV AEFI monitoring
Communicating with caregivers about IPV and multiple injections
المرحلة القادمة من القضاء على شلل الأطفال واللقاحات المستخدمة
World Health Organization
Recording and monitoring uptake of JE vaccine
World Health Organization
Module 6 Rotavirus vaccine AEFI monitoring
JE vaccine eligibility
World Health Organization
Recording and monitoring uptake of fractional IPV (fIPV)
The next phase of polio eradication and the vaccines used
Module 8 Safety and acceptability of multiple injections
Module 6 Rotavirus vaccine AEFI monitoring
Module 3 Rotavirus vaccine eligibility
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Module 4 Rotavirus vaccine administration
Module 3 Rotavirus vaccine eligibility
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 3 Rotavirus vaccine eligibility
Module 6 Rotavirus vaccine AEFI monitoring
The next phase of polio eradication and the vaccines used
World Health Organization
World Health Organization
Presentation transcript:

Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction

IPV schedule, eligibility and contraindications, Module 3 | February |2 | Learning objectives At the end of the module, the participant will be able to: – Describe the recommended immunization schedule for inactivated poliovirus vaccine (IPV) – Determine when an infant can receive IPV – Describe the absolute contraindications for vaccination and understand the false-contraindications Duration – 25minutes

IPV schedule, eligibility and contraindications, Module 3 | February |3 | Key issues What is the recommended schedule for IPV? 1 1 What are the true and false contraindications to vaccination? 2 2 Can you administer IPV to immunodeficient or premature infants? 3 3

IPV schedule, eligibility and contraindications, Module 3 | February |4 | When should IPV be administered? Schedule BasicBooster 1st2nd3rd1st2nd First option IPV OPV Alternate option IPVOPV Vaccination Schedule recommended for the introduction of inactivated poliovirus vaccine (IPV) in combination with the oral poliovirus vaccine (OPV). The TAG recommends that countries use a sequential schedule, preferably: IPV + IPV + OPV + OPV + OPV The second option is one dose of IPV followed by two doses of OPV for the regular schedule and two OPV doses as boosters

IPV schedule, eligibility and contraindications, Module 3 | February |5 | Why introduce IPV as first (and second) doses in schedule? Very rarely, tOPV can cause vaccine-associated paralytic polio (VAPP) The incidence of VAPP in the Region is around 1 case per 7.68 million doses administered. 49% of VAPP cases in the Region are associated with the first dose of OPV, and 21% are associated with the second dose. Introducing IPV at the first immunization contact will be a reduction in VAPP incidence by around 50%.

IPV schedule, eligibility and contraindications, Module 3 | February |6 | A child comes in at 4 months of age and has had no vaccines. What should you do? What should you do in this scenario?

IPV schedule, eligibility and contraindications, Module 3 | February |7 | Answer: The child should receive the first dose of IPV and other vaccines according to national schedule. Explain to the caretaker the importance of coming for vaccination on time and completing the immunization schedule Prepare/update the immunization card

IPV schedule, eligibility and contraindications, Module 3 | February |8 | Absolute contraindications to IPV Do not vaccinate if recipient has: Known or documented allergy to vaccine components, including: -Streptomycin -Neomycin -Polymyxin B History of an allergic reaction following a previous IPV injection Thrombocytopenia (insufficient blood platelets, which play an important role in coagulation) Other bleeding disorder Wait! Postpone vaccination if recipient is: Taking temporary treatment that suppresses the immune response -Treatment could reduce immune response to the vaccine -Postpone vaccination until the end of the treatment to make sure the infant is well protected by the vaccine

IPV schedule, eligibility and contraindications, Module 3 | February |9 | Can IPV be administered on schedule to immunodeficient infants or infants born prematurely? Yes! Immunodeficiency is not a contraindication of IPV Vaccination of infants with immunodeficiency, such as HIV infection, is recommended Infants born prematurely should receive IPV on schedule

IPV schedule, eligibility and contraindications, Module 3 | February | Contraindication Checklist Do I still give IPV if recipient has….?YesNoPostpone …mild illness …malnutrition …HIV …prematurity …allergy to streptomycin, neomycin or polymyxin B …bleeding disorder …had a previous severe reaction to IPV …taking treatment that suppresses immune response

IPV schedule, eligibility and contraindications, Module 3 | February | Key messages TAG recommended schedule: IPV can be given at the same time as other injectable vaccines like pentavalent and pneumococcal vaccine IPV can be administered to children with immunodeficiency disorders and those born prematurely Schedule BasicBooster 1st2nd3rd1st2nd First option IPV OPV Alternate option IPVOPV

IPV schedule, eligibility and contraindications, Module 3 | February | End of module Thank you for your attention!